天美传媒

Journal of Clinical Diabetes
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Clin Diabetes 2023, Vol 7(4): 180
  • DOI: 10.4172/jcds.1000180

A GFP Retinal Prion Proteins Intracellular Trafficking via Endocytic Intermediates

Tarunkanti Mondal*
Department of Clinical Diabetes and Research, University of Bhubaneswar, India
*Corresponding Author : Tarunkanti Mondal, Department of Clinical Diabetes and Research, University of Bhubaneswar, India, Email: tarunkantimondal447@gmail.com

Received Date: Jul 05, 2023 / Accepted Date: Jul 29, 2023 / Published Date: Jul 31, 2023

Abstract

The prion protein (PrP) is a key molecule implicated in neurodegenerative disorders. Understanding its intracellular trafficking is essential for unraveling its physiological and pathological functions. This article focuses on the intracellular trafficking of a green fluorescent protein (GFP) tagged PrP in retinal cells, specifically exploring its transport via endocytic intermediates. Endocytic pathways, including clathrin-mediated endocytosis, caveolaemediated endocytosis, and macropinocytosis, play a crucial role in PrP internalization and trafficking. Endocytic intermediates, such as early endosomes, late endosomes, and lysosomes, are involved in sorting, recycling, and degradation of endocytosed proteins. Live-cell imaging and colocalization studies have provided insights into GFPPrP’s movement and localization within these organelles. Studies reveal rapid internalization of PrP via clathrinmediated endocytosis, with subsequent transport to early endosomes. A fraction of PrP is recycled, while the remainder progresses to late endosomes and lysosomes for degradation. Elucidating the intracellular trafficking of GFP-PrP and its association with endocytic intermediates enhances our understanding of PrP’s functions and implications in neurodegenerative diseases. Further investigations are needed to explore the molecular machinery involved and the impact of disease-associated mutations. This knowledge may contribute to potential therapeutic strategies for prion diseases.

Citation: Mondal T (2023) A GFP Retinal Prion Protein’s Intracellular Trafficking via Endocytic Intermediates. J Clin Diabetes 7: 180. Doi: 10.4172/jcds.1000180

Copyright: © 2023 Mondal T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top